Mortensen KN, Gjedde A, Thompson GJ, Herman P, Parent MJ, Rothman DL, et al
GLP-1 is a hormone that is naturally produced in the small intestines
Among its strengths is its status as the largest study to date that focuses on the association between GLP-1 RA usage and the risk of psychiatric outcomes in real-world scenarios
Finally, tirzepatide was associated with significantly reduced occurrence of a composite kidney outcome comprising new-onset MA, 40% eGFR decline, end-stage renal disease and death due to kidney failure (HR 0.58, 95% CI 0.430.80) [49]
Its important to always have an in-depth conversation with your prescribing doctor or nurse before considering them and be aware of the potential risks
Be back tomorrow morning with another episode of USA TODAY's The Excerpt.